These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 38065968)
1. FilGAP regulates tumor growth in Glioma through the regulation of mTORC1 and mTORC2. Tsutsumi K; Nohara A; Tanaka T; Murano M; Miyagaki Y; Ohta Y Sci Rep; 2023 Dec; 13(1):20956. PubMed ID: 38065968 [TBL] [Abstract][Full Text] [Related]
2. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects. Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457 [TBL] [Abstract][Full Text] [Related]
3. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma. Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736 [TBL] [Abstract][Full Text] [Related]
4. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship. Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692 [TBL] [Abstract][Full Text] [Related]
5. Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation. Kazyken D; Lentz SI; Wadley M; Fingar DC J Biol Chem; 2023 Sep; 299(9):105097. PubMed ID: 37507012 [TBL] [Abstract][Full Text] [Related]
6. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
7. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes. Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674 [TBL] [Abstract][Full Text] [Related]
8. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes. Weinberg MA Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392 [TBL] [Abstract][Full Text] [Related]
9. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets. Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD Cells; 2024 Feb; 13(5):. PubMed ID: 38474373 [TBL] [Abstract][Full Text] [Related]
10. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
11. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism. Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304 [TBL] [Abstract][Full Text] [Related]
12. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Liu P; Gan W; Inuzuka H; Lazorchak AS; Gao D; Arojo O; Liu D; Wan L; Zhai B; Yu Y; Yuan M; Kim BM; Shaik S; Menon S; Gygi SP; Lee TH; Asara JM; Manning BD; Blenis J; Su B; Wei W Nat Cell Biol; 2013 Nov; 15(11):1340-50. PubMed ID: 24161930 [TBL] [Abstract][Full Text] [Related]
13. Identification of rictor as a novel substrate of Polo-like kinase 1. Shao T; Liu X Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006 [TBL] [Abstract][Full Text] [Related]
14. Cystine Induced-mTORC2 Activation through Promoting Sin1 Phosphorylation to Suppress Cancer Cell Ferroptosis. Wang G; Chen L; Qin S; Zheng Y; Xia C; Yao J; Wang P; Deng L Mol Nutr Food Res; 2022 Dec; 66(23):e2200186. PubMed ID: 36189894 [TBL] [Abstract][Full Text] [Related]
16. Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Breuleux M; Klopfenstein M; Stephan C; Doughty CA; Barys L; Maira SM; Kwiatkowski D; Lane HA Mol Cancer Ther; 2009 Apr; 8(4):742-53. PubMed ID: 19372546 [TBL] [Abstract][Full Text] [Related]
17. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Wang B; Jie Z; Joo D; Ordureau A; Liu P; Gan W; Guo J; Zhang J; North BJ; Dai X; Cheng X; Bian X; Zhang L; Harper JW; Sun SC; Wei W Nature; 2017 May; 545(7654):365-369. PubMed ID: 28489822 [TBL] [Abstract][Full Text] [Related]
18. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). García-Martínez JM; Alessi DR Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875 [TBL] [Abstract][Full Text] [Related]
19. Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Saci A; Cantley LC; Carpenter CL Mol Cell; 2011 Apr; 42(1):50-61. PubMed ID: 21474067 [TBL] [Abstract][Full Text] [Related]
20. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]